The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. “Saliva testing will help with the global shortage of swabs for sampling and increase testing […]
Recent Posts
- FDA’s Bold Move on Ingestible Fluoride: What Dentists Need to Know Globally
- When AI, Dentists, and Patients Don’t Agree: Who Decides What’s “Right” in Dental Care?
- Revolutionary Keratin Toothpaste Promises Enamel Renewal
- Nobel Prize 2025: Immune System Pioneers Honored – A Triumph for Medical Science with Lessons for Dentistry
- How Oral Bacteria May Predict Pancreatic Cancer: New Research Insights
Archives